MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries. in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits, and bioinformatics analysis; lab automation products, which includes automation system and sample treatment kits; and novel products, comprising single-cell platform, ultrasound platform, and BIT platform. The company's platforms include genetic sequencing, medical imaging, and laboratory automation. Its solutions are used for forensic, population, and agricultural genomics applications. It has a collaboration with Prepaire Labs to advance drug discovery and precision medicine; and Oncoclínicas&Co to expand access to cutting-edge genomic tests and strengthen diagnostic capabilities in the field of oncology. The company was founded in 2016 and is headquartered in Shenzhen, China.